tradingkey.logo
tradingkey.logo
Pesquisar

ICAD Inc

ICAD
Adicionar à lista de desejos
3.870USD
0.0000.00%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
105.19MValor de mercado
PerdaP/L TTM

Mais detalhes de ICAD Inc Empresa

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

Informações de ICAD Inc

Código da empresaICAD
Nome da EmpresaICAD Inc
Data de listagemDec 13, 1984
CEOMs. Dana R. Brown
Número de funcionários66
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 13
Endereço98 Spit Brook Rd Ste 100
CidadeNASHUA
Bolsa de valoresEuronext Paris
PaísUnited States of America
Código postal03062-5737
Telefone16038825200
Sitehttps://www.icadmed.com/
Código da empresaICAD
Data de listagemDec 13, 1984
CEOMs. Dana R. Brown

Executivos da empresa ICAD Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jonathan Go
Mr. Jonathan Go
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Dr. Hedvig Hricak, M.D., Ph.D.
Dr. Hedvig Hricak, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Susan Alyson Wood, Ph.D.
Dr. Susan Alyson Wood, Ph.D.
Independent Director
Independent Director
--
-100.00%
John Nesbett
John Nesbett
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de ICAD Inc?

Os cinco principais acionistas de ICAD Inc são: Mr. Eric Lonnqvist

Quantas instituições possuem ações da ICAD Inc (ICAD)?

Em 2025Q2, 117 instituições possuíam ações da ICAD Inc, com valor de mercado aproximado de 9.75M, representando 35.51% do total de ações. Em comparação com 2025Q1, a participação institucional aumentou em 1190732.00.

Qual é a maior fonte de receita da ICAD Inc?

Em 2025Q2, o segmento de negócios Subscription term licenses gerou a maior receita para ICAD Inc, totalizando 1.78M e representando 36.62% da receita total.